Impella RP versus pharmacologic vasoactive treatment in profound cardiogenic shock due to right ventricular failure: Unloading and end-organ perfusion in a large animal model

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Foundation. Main funding source(s): The Danish Heart Foundation Unrestricted research grant from Abiomed BACKGROUND: No strong evidence exists regarding the treatment of cardiogenic shock (CS) caused by acute right ventricular (RV) failure which has...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Eur Heart J Acute Cardiovasc Care
Huvudupphovsmän: Josiassen, J, Helgestad, OKL, Udesen, NLJ, Banke, A, Frederiksen, PH, Schmidt, H, Jensen, LO, Hassager, C, Moeller, JE, Ravn, HB
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2021
Ämnen:
19.4 - Cardiogenic Shock
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8264033/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjacc/zuab020.170
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk